A comparative genomics and transgenic approach to regulation of IL-10 expression
调节 IL-10 表达的比较基因组学和转基因方法
基本信息
- 批准号:8081828
- 负责人:
- 金额:$ 39.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAllergicAutoimmune ProcessB-LymphocytesBackcrossingsBacterial Artificial ChromosomesBinding SitesBiochemicalBiological AssayBiological ProcessCell LineageCellsChromatin StructureChromosomes, Human, Pair 1ColitisDNADNA BindingDataDetectionDiseaseDisease susceptibilityDoseElectrophoretic Mobility Shift AssayElementsEnzyme-Linked Immunosorbent AssayEpigenetic ProcessEtiologyEvaluationFunctional RNAGene ClusterGene ExpressionGene TargetingGenesGeneticGenetic TranscriptionGenetic VariationGenomicsGoalsH19 geneHomologous GeneHumanHuman ChromosomesHypersensitivityIL10 geneIL19 geneIn VitroIndiumInflammationInterleukin-10Knockout MiceLaboratoriesLengthLinkLymphoidMAPKAPK2 geneMalignant NeoplasmsMapsModelingModificationMolecularMolecular GeneticsMolecular ProfilingMonitorMusMyelogenousNatural Killer CellsNucleic Acid Regulatory SequencesPathogenesisPathway interactionsPatternPhenotypePlayPopulationPredispositionPrincipal InvestigatorProductionReceptor CellRegulationRegulator GenesRegulatory ElementRegulatory PathwayResearchResearch PersonnelRoleSequence AlignmentSequence AnalysisSignal PathwaySignal TransductionSiteStructureT-LymphocyteTestingTimeTissuesTranscriptTranscriptional RegulationTransgenic MiceTransgenic ModelTransgenic OrganismsVariantWorkbasebisulfitecell typechromatin immunoprecipitationchromatin remodelingcomparative genomicscytokinedesignhuman tissuein vivoin vivo Modelinsightinterleukin-19macrophagenew therapeutic targetnovelprogramspromoterreceptorresponsetooltranscription factor
项目摘要
DESCRIPTION (provided by applicant): IL-10 is an immunoregulatory cytokine that plays a fundamental role in limiting inflammation. Very little is known about the mechanisms which control human IL-10 expression. Our broad goal is to define regulatory pathways and genomic requirements which control human IL-10 expression profiles. The specific hypothesis is that cell-type and receptor-specific human IL-10 expression patterns, are controlled by evolutionary conserved regulatory regions that encompass the il10 gene and extend into the flanking genes il19 and mapkapk2. We base this hypothesis on the observations that 1) the il10 gene is located in a syntenic cluster of 1110 homologues, 2) sequence alignments around the il10 gene cluster indicate numerous regions of homology between species, known as conserved non-coding sequences (CMS) which frequently harbor regulatory elements, 3) data from our laboratory and others show evidence of tissue-specific chromatin structure and expression profiles between il10 and its flanking genes 1119 and mapkapk2. To study genomic requirements of human IL-10 regulation, we have developed a transgenic mouse based on a bacterial artificial chromosome (BAC) which contains the human il10 gene as well as the flanking genes il19 and mapkapk2 (hIL10BAC mice). We believe the 175 kb BAC contains the genomic information to impart cell-specific expression of human IL-10. We have validated tissue-specific expression of human IL-10 in vivo and in vitro in hIL10BAC mice. The specific aims will: 1. Define tissue- and receptor-specific pathways which regulate human IL-10 transcription in Hil10BAC mice. We will characterize cell-specific human IL-10 induction patterns and identify mechanisms which underlie tissue-specific gene transcription by identifying; (i) regulatory boundaries between human i!10 and the flanking genes ill9 and mapkapk2, (ii) the presence/absence of human, tissue-specific intergenic transcripts and (iii) human IL-10 expression deficiencies in transcription factor null mice backcrossed to the hIL10BAC mice. 2. Determine epigenetic/genomic requirements for human IL-10 expression in hIL10BAC mice. We are targeting CMS sites in the human IL-10 BAC and using these sites as a guide to determine the extended chromatin structure surrounding the human il10 gene. 3. Determine if the hIL10BAC mouse is an appropriate in vivo model for analysis of genomic structure and biological function by; by crossing the hIL10BAC mice to the IL10-/- mouse (lL10BAC?/-) and attempting to rescue IL10-/- phenotypes focusing on LPS hypersensitivity models.
描述(由申请人提供):IL-10是一种免疫调节细胞因子,在限制炎症中起着基本作用。关于控制人IL-10表达的机制知之甚少。我们的广泛目标是定义控制人IL-10表达曲线的调节途径和基因组要求。特定的假设是细胞类型和受体特异性的人IL-10表达模式,由涵盖IL10基因的进化保守调节区控制,并延伸到侧翼基因IL19和MAPKAPK2。 We base this hypothesis on the observations that 1) the il10 gene is located in a syntenic cluster of 1110 homologues, 2) sequence alignments around the il10 gene cluster indicate numerous regions of homology between species, known as conserved non-coding sequences (CMS) which frequently harbor regulatory elements, 3) data from our laboratory and others show evidence of tissue-specific chromatin structure and expression profiles between il10 and its侧面基因1119和MAPKAPK2。为了研究人类IL-10调节的基因组要求,我们基于细菌人工染色体(BAC)开发了一种转基因小鼠,该染色体(BAC)包含人类IL10基因以及侧翼基因IL19和MAPKAPK2(HIL10BAC小鼠)。我们认为175 kb的BAC包含基因组信息,以赋予人IL-10的细胞特异性表达。我们已经验证了人体内人IL-10的组织特异性表达和在HIL10BAC小鼠中的体外表达。具体目的将:1。定义组织和受体特异性途径,这些途径调节HIL10BAC小鼠的人IL-10转录。我们将表征细胞特异性的人IL-10诱导模式,并确定通过识别组织特异性基因转录基础的机制。 (i)人I!10与侧翼基因ILL9和MAPKAPK2之间的调节界限,(ii)人类,组织特异性基因间转录物的存在/不存在(III)人IL-10表达不足,在转录因子无效的NULL小鼠中反向HIL10BAC小鼠回到HIL10BAC小鼠中。 2。确定HIL10BAC小鼠中人IL-10表达的表观遗传/基因组需求。我们针对人IL-10 BAC中的CMS位点,并使用这些位点作为确定围绕人IL10基因的扩展染色质结构的指南。 3。确定HIL10BAC小鼠是否是用于分析基因组结构和生物学功能的合适的体内模型;通过将HIL10BAC小鼠跨到IL10 - / - 小鼠(LL10BAC?/ - ),并尝试挽救针对LPS超敏反应模型的IL10 - / - 表型。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cell type-specific regulation of IL-10 expression in inflammation and disease.
- DOI:10.1007/s12026-009-8150-5
- 发表时间:2010-07
- 期刊:
- 影响因子:4.4
- 作者:Hedrich CM;Bream JH
- 通讯作者:Bream JH
Dynamic DNA methylation patterns across the mouse and human IL10 genes during CD4+ T cell activation; influence of IL-27.
- DOI:10.1016/j.molimm.2010.09.009
- 发表时间:2010-11
- 期刊:
- 影响因子:3.6
- 作者:Hedrich CM;Ramakrishnan A;Dabitao D;Wang F;Ranatunga D;Bream JH
- 通讯作者:Bream JH
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jay H. Bream其他文献
A human IL10 BAC transgene reveals tissue-specific control of IL-10 expression: Implications on disease outcomes
- DOI:
10.1016/j.cyto.2009.07.250 - 发表时间:
2009-10-01 - 期刊:
- 影响因子:
- 作者:
Jay H. Bream;Dilini Ranatunga;Christian M. Hedrich;Fengying Wang;Daniel W. McVicar;Nathan Nowak;Trupti Joshi;Lionel Feigenbaum;Lindsay R. Grant;Simona Stäger - 通讯作者:
Simona Stäger
Jay H. Bream的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jay H. Bream', 18)}}的其他基金
Profiling the immune response to convalescent plasma therapy during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
分析严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 感染期间恢复期血浆治疗的免疫反应
- 批准号:
10373738 - 财政年份:2022
- 资助金额:
$ 39.42万 - 项目类别:
Profiling the immune response to convalescent plasma therapy during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
分析严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 感染期间恢复期血浆治疗的免疫反应
- 批准号:
10609455 - 财政年份:2022
- 资助金额:
$ 39.42万 - 项目类别:
Leveraging an ongoing longitudinal study of influenza vaccination to define immune signatures of response and risk of infection in older adults >75
利用正在进行的流感疫苗接种纵向研究来定义 75 岁以上老年人的免疫反应特征和感染风险
- 批准号:
10347918 - 财政年份:2021
- 资助金额:
$ 39.42万 - 项目类别:
Leveraging an ongoing longitudinal study of influenza vaccination to define immune signatures of response and risk of infection in older adults >75
利用正在进行的流感疫苗接种纵向研究来定义 75 岁以上老年人的免疫反应特征和感染风险
- 批准号:
10538598 - 财政年份:2021
- 资助金额:
$ 39.42万 - 项目类别:
The use of genetically humanized IL-10 mice to determine the molecular basis of a
使用基因人源化 IL-10 小鼠来确定 IL-10 的分子基础
- 批准号:
8776126 - 财政年份:2014
- 资助金额:
$ 39.42万 - 项目类别:
The use of genetically humanized IL-10 mice to determine the molecular basis of allele-specific gene expression and disease susceptibility
使用基因人源化 IL-10 小鼠确定等位基因特异性基因表达和疾病易感性的分子基础
- 批准号:
9278093 - 财政年份:2014
- 资助金额:
$ 39.42万 - 项目类别:
A comparative genomics and transgenic approach to regulation of IL-10 expression
调节 IL-10 表达的比较基因组学和转基因方法
- 批准号:
7316983 - 财政年份:2007
- 资助金额:
$ 39.42万 - 项目类别:
A comparative genomics and transgenic approach to regulation of IL-10 expression
调节 IL-10 表达的比较基因组学和转基因方法
- 批准号:
7900571 - 财政年份:2007
- 资助金额:
$ 39.42万 - 项目类别:
A comparative genomics and transgenic approach to regulation of IL-10 expression
调节 IL-10 表达的比较基因组学和转基因方法
- 批准号:
7657340 - 财政年份:2007
- 资助金额:
$ 39.42万 - 项目类别:
A comparative genomics and transgenic approach to regulation of IL-10 expression
调节 IL-10 表达的比较基因组学和转基因方法
- 批准号:
7436150 - 财政年份:2007
- 资助金额:
$ 39.42万 - 项目类别:
相似国自然基金
翻译后修饰影响卵清蛋白过敏表位的分子机制
- 批准号:32372336
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CD207阳性树突状细胞在过敏性哮喘气道炎症中作用及机制研究
- 批准号:82370035
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
鼠李糖乳杆菌通过肠-肺轴调控AhR/Nrf2/ROS/STAT6通路改善过敏性哮喘气道黏液高分泌的作用及机制研究
- 批准号:82370043
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
海马PRG-1通过谷氨酸通路介导突触重塑缓解新生期伤害致持续痛觉过敏的机制研究
- 批准号:82360232
- 批准年份:2023
- 资助金额:32.2 万元
- 项目类别:地区科学基金项目
花生主要过敏原 Ara h 3 致敏的结构生物学基础
- 批准号:32372441
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
A comparative genomics and transgenic approach to regulation of IL-10 expression
调节 IL-10 表达的比较基因组学和转基因方法
- 批准号:
7316983 - 财政年份:2007
- 资助金额:
$ 39.42万 - 项目类别:
A comparative genomics and transgenic approach to regulation of IL-10 expression
调节 IL-10 表达的比较基因组学和转基因方法
- 批准号:
7900571 - 财政年份:2007
- 资助金额:
$ 39.42万 - 项目类别:
Molecular identification of a sialyl 9-O-acetyl transferase
唾液酸9-O-乙酰基转移酶的分子鉴定
- 批准号:
7371081 - 财政年份:2007
- 资助金额:
$ 39.42万 - 项目类别:
A comparative genomics and transgenic approach to regulation of IL-10 expression
调节 IL-10 表达的比较基因组学和转基因方法
- 批准号:
7657340 - 财政年份:2007
- 资助金额:
$ 39.42万 - 项目类别:
Molecular identification of a sialyl 9-O-acetyl transferase
唾液酸9-O-乙酰基转移酶的分子鉴定
- 批准号:
7213530 - 财政年份:2007
- 资助金额:
$ 39.42万 - 项目类别: